CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leader in Advanced Organ (AOP) technology, is glad to announce that we are attending and supporting AST CEoT Transplant Summit on Feb 23, 2023.
CEoT 2023 will focus on identifying the barriers that exist for patients on this complex journey to organ transplantation and more importantly focuses on providing innovative strategies and potential solutions to overcome these barriers to optimize access for all solid organ transplant candidates. We will examine each step in the process as defined above and these steps will serve as the backbone for discussion during each of the sessions during the meeting. Our sessions will also include active participation from transplant recipients both in show casing their transplantation journey as well as panel discussants so that all in the audience can learn from experts in the field as well as the patient experience moving along the transplant process.
About Paragonix Technologies
Paragonix Technologies creates organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix is a leading provider of FDA cleared and CE marked transport devices for organ preservation.
Follow us on Twitter: @ParagonixSherpa
Connect with us on LinkedIn: Paragonix Technologies
Like Us on Facebook: Paragonix SherpaPak
L-399 Rev 1
Adam Lafreniere, Sr. Director, Marketing
FlightAware® is a registered trademark of FlightAware, a division of Collins Aerospace